ORAGENICS, INC. Debt Conversion, Converted Instrument, Amount
ORAGENICS, INC. (OGEN) reported Debt Conversion, Converted Instrument, Amount of $11.28 million for the 12-month period ending 2012-12-31, per its 10-K filed 2014-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2014-02-28
- ORAGENICS, INC. debt conversion, converted instrument, amount for the quarter ending 2012-12-31 was $0.00.
- ORAGENICS, INC. debt conversion, converted instrument, amount for the quarter ending 2012-09-30 was $2.54M.
- ORAGENICS, INC. debt conversion, converted instrument, amount for the quarter ending 2012-06-30 was $0.00.
- ORAGENICS, INC. debt conversion, converted instrument, amount for the quarter ending 2012-03-31 was $8.74M.
- ORAGENICS, INC. debt conversion, converted instrument, amount for fiscal 2012 was $11.28M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $2.54M derived: sum of 2 quarters · filed 2014-02-28 | $2.54M derived: sum of 3 quarters · filed 2014-02-28 | $11.28M 10-K · filed 2014-02-28 |
| 2012-09-30 | $2.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-25 | $2.54M derived: sum of 2 quarters · filed 2013-10-25 | $11.28M 10-Q · filed 2013-10-25 | |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $8.74M 10-Q · filed 2013-08-12 | ||
| 2012-03-31 | $8.74M 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |